A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.

Gene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Payel Ganguly, Landiso Madonsela, Jesse T Chao, Christopher J R Loewen, Timothy P O'Connor, Esther M Verheyen, Douglas W Allan
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Genetics QH426-470
Acceso en línea:	https://doaj.org/article/5cb487758be84e0eb6cf26744bfaff89
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5cb487758be84e0eb6cf26744bfaff89
record_format	dspace
spelling	oai:doaj.org-article:5cb487758be84e0eb6cf26744bfaff892021-12-02T20:03:21ZA scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.1553-73901553-740410.1371/journal.pgen.1009774https://doaj.org/article/5cb487758be84e0eb6cf26744bfaff892021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.pgen.1009774https://doaj.org/toc/1553-7390https://doaj.org/toc/1553-7404Gene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these assays reproducible, scalable to high numbers of variants, and capable of assessing defined gene-disease mechanism for clinical interpretation aligned to the ClinGen Sequence Variant Interpretation (SVI) Working Group guidelines for 'well-established assays'. Drosophila melanogaster offers great potential as an assay platform, but was untested for high numbers of human variants adherent to these guidelines. Here, we wished to test the utility of Drosophila as a platform for scalable well-established assays. We took a genetic interaction approach to test the function of ~100 human PTEN variants in cancer-relevant suppression of PI3K/AKT signaling in cellular growth and proliferation. We validated the assay using biochemically characterized PTEN mutants as well as 23 total known pathogenic and benign PTEN variants, all of which the assay correctly assigned into predicted functional categories. Additionally, function calls for these variants correlated very well with our recent published data from a human cell line. Finally, using these pathogenic and benign variants to calibrate the assay, we could set readout thresholds for clinical interpretation of the pathogenicity of 70 other PTEN variants. Overall, we demonstrate that Drosophila offers a powerful assay platform for clinical variant interpretation, that can be used in conjunction with other well-established assays, to increase confidence in the accurate assessment of variant function and pathogenicity.Payel GangulyLandiso MadonselaJesse T ChaoChristopher J R LoewenTimothy P O'ConnorEsther M VerheyenDouglas W AllanPublic Library of Science (PLoS)articleGeneticsQH426-470ENPLoS Genetics, Vol 17, Iss 9, p e1009774 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Genetics QH426-470
spellingShingle	Genetics QH426-470 Payel Ganguly Landiso Madonsela Jesse T Chao Christopher J R Loewen Timothy P O'Connor Esther M Verheyen Douglas W Allan A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
description	Gene variant discovery is becoming routine, but it remains difficult to usefully interpret the functional consequence or disease relevance of most variants. To fill this interpretation gap, experimental assays of variant function are becoming common place. Yet, it remains challenging to make these assays reproducible, scalable to high numbers of variants, and capable of assessing defined gene-disease mechanism for clinical interpretation aligned to the ClinGen Sequence Variant Interpretation (SVI) Working Group guidelines for 'well-established assays'. Drosophila melanogaster offers great potential as an assay platform, but was untested for high numbers of human variants adherent to these guidelines. Here, we wished to test the utility of Drosophila as a platform for scalable well-established assays. We took a genetic interaction approach to test the function of ~100 human PTEN variants in cancer-relevant suppression of PI3K/AKT signaling in cellular growth and proliferation. We validated the assay using biochemically characterized PTEN mutants as well as 23 total known pathogenic and benign PTEN variants, all of which the assay correctly assigned into predicted functional categories. Additionally, function calls for these variants correlated very well with our recent published data from a human cell line. Finally, using these pathogenic and benign variants to calibrate the assay, we could set readout thresholds for clinical interpretation of the pathogenicity of 70 other PTEN variants. Overall, we demonstrate that Drosophila offers a powerful assay platform for clinical variant interpretation, that can be used in conjunction with other well-established assays, to increase confidence in the accurate assessment of variant function and pathogenicity.
format	article
author	Payel Ganguly Landiso Madonsela Jesse T Chao Christopher J R Loewen Timothy P O'Connor Esther M Verheyen Douglas W Allan
author_facet	Payel Ganguly Landiso Madonsela Jesse T Chao Christopher J R Loewen Timothy P O'Connor Esther M Verheyen Douglas W Allan
author_sort	Payel Ganguly
title	A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_short	A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_full	A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_fullStr	A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_full_unstemmed	A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.
title_sort	scalable drosophila assay for clinical interpretation of human pten variants in suppression of pi3k/akt induced cellular proliferation.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/5cb487758be84e0eb6cf26744bfaff89
work_keys_str_mv	AT payelganguly ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT landisomadonsela ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT jessetchao ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT christopherjrloewen ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT timothypoconnor ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT esthermverheyen ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT douglaswallan ascalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT payelganguly scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT landisomadonsela scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT jessetchao scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT christopherjrloewen scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT timothypoconnor scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT esthermverheyen scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation AT douglaswallan scalabledrosophilaassayforclinicalinterpretationofhumanptenvariantsinsuppressionofpi3kaktinducedcellularproliferation
_version_	1718375662022033408

A scalable Drosophila assay for clinical interpretation of human PTEN variants in suppression of PI3K/AKT induced cellular proliferation.

Ejemplares similares